MetaVia is trading 5.7% higher at $1.30 after closing at $1.23 on October 19, 2026; no clear catalyst for the after-hours rise has been identified.
- The supplied price context shows a rebound after two consecutive down sessions; after-hours volume and activity details were not provided.
- No fresh company-specific announcement was found. MetaVia’s latest listed announcement was Sarah Browne’s October 13 appointment as chief medical officer. Broad market information is mixed, with no clear market-wide or company-specific cause established.